These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 2403813
1. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1. Franke AE, Danley DE, Kaczmarek FS, Hawrylik SJ, Gerard RD, Lee SE, Geoghegan KF. Biochim Biophys Acta; 1990 Jan 19; 1037(1):16-23. PubMed ID: 2403813 [Abstract] [Full Text] [Related]
2. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells. Lawrence D, Strandberg L, Grundström T, Ny T. Eur J Biochem; 1989 Dec 22; 186(3):523-33. PubMed ID: 2514093 [Abstract] [Full Text] [Related]
5. High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coli. Sisk WP, Davis GL, Kingsley D, Chiu AT, Reilly TM. Gene; 1990 Dec 15; 96(2):305-9. PubMed ID: 2269442 [Abstract] [Full Text] [Related]
6. Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli. Seetharam R, Dwivedi AM, Duke JL, Hayman AC, Walton HL, Huckins NR, Kamerkar SM, Corman JI, Woodeshick RW, Wilk RR. Biochemistry; 1992 Oct 20; 31(41):9877-82. PubMed ID: 1382596 [Abstract] [Full Text] [Related]
7. Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae. Steven J, Cottingham IR, Berry SJ, Chinery SA, Goodey AR, Courtney M, Ballance DJ. Eur J Biochem; 1991 Mar 14; 196(2):431-8. PubMed ID: 1901039 [Abstract] [Full Text] [Related]
8. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies. Lee HJ, Im H. Protein Expr Purif; 2003 Sep 14; 31(1):99-107. PubMed ID: 12963346 [Abstract] [Full Text] [Related]
9. Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms. Hekman CM, Loskutoff DJ. Biochemistry; 1988 Apr 19; 27(8):2911-8. PubMed ID: 2969749 [Abstract] [Full Text] [Related]
10. Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1. Strömqvist M, Andersson JO, Boström S, Deinum J, Ehnebom J, Enquist K, Johansson T, Hansson L. Protein Expr Purif; 1994 Aug 19; 5(4):309-16. PubMed ID: 7950376 [Abstract] [Full Text] [Related]
11. Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coli. Sancho E, Tonge DW, Hockney RC, Booth NA. Eur J Biochem; 1994 Aug 15; 224(1):125-34. PubMed ID: 8076633 [Abstract] [Full Text] [Related]
19. High-level expression of active human plasminogen activator inhibitor type 1 (PAI-1) in E. coli. Zhou A, Pei Y, Wu H, Dong X, Xu X. Biochem Mol Biol Int; 1996 May 01; 39(2):235-42. PubMed ID: 8799449 [Abstract] [Full Text] [Related]
20. Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells. Laug WE, Aebersold R, Jong A, Rideout W, Bergman BL, Baker J. Thromb Haemost; 1989 Jun 30; 61(3):517-21. PubMed ID: 2799763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]